Why Noninvasive Blood Glucose Monitoring Is Nonetheless the Holy Grail of Wearables

At the beginning of 2014, Google introduced an initiative that, if profitable, appeared destined to place Silicon Valley as a serious drive within the healthcare house.

In a blog post, the corporate disclosed that it had begun creating a sensible contact lens prototype that would measure glucose ranges in tears through a miniaturized sensor nestled inside its layers. The prototypes may reportedly generate a studying as soon as each second.

If the know-how had proved profitable, it might have completed two massive issues. First, it might have been a game-changer for the roughly 830 million people residing with diabetes worldwide, as it might have supplied a far simpler means for frequent glucose monitoring, which is tied to higher long-term well being outcomes. But it might have additionally been a breakthrough for shopper wearables. A profitable sensible lens would have confirmed {that a} main tech firm may remedy a core biomedical downside and would have allowed Google to compete with conventional medical-device firms and make it a professional participant inside the healthcare house.

But it didn’t occur.

Despite the fanfare and anticipation surrounding the announcement, simply two years into the enterprise, reporting, including a 2016 STAT investigation, confirmed that the venture was plagued by setbacks. The fundamental situation was one in all primary science: tears have been merely an unreliable fluid for measuring ranges of blood glucose. On a bigger scale it additionally revealed just a few different points surrounding the merger of shopper tech and healthcare. For one, miniaturizing {hardware} will not be at all times sufficient, as human biology is noisy and messy. And second, medical gadgets require extraordinarily correct, dependable information. A tool that estimates each day step rely can, for apparent causes, be ok, however one which measures blood glucose readings in folks with diabetes? Good sufficient gained’t reduce it.

Today, scientists are nonetheless engaged on nailing down what stays to be one of many holy grails of wearables: really noninvasive glucose monitoring. Unlike sensible contact lenses, these gadgets wouldn’t contact bodily fluids. Instead, they’d detect glucose’s distinctive molecular signature via the pores and skin, after which use that sign to estimate blood glucose ranges not directly. This stays one of the crucial difficult issues in biomedical engineering. But researchers are slowly chipping away on the physics, chemistry, and supplies science wanted to succeed in this purpose—and they’re nearer than ever.

Signal to noise

Google’s sensible contact lenses failed due to a key organic situation: our physique has a bunch of stuff floating round within it, and glucose is only one extraordinarily small part.

When somebody pricks their finger to measure their glucose ranges, they place a tiny drop of blood on a disposable take a look at strip. Those take a look at strips include an enzyme that reacts particularly with the glucose contained in that drop of blood. During the response, glucose is oxidized and releases electrons, that are transferred via mediator chemical compounds to tiny electrodes within the strip. The glucose meter measures the ensuing electrical present, and since extra glucose produces extra electron move, the meter can calculate the blood glucose focus. Continuous glucose screens (CGMs) work utilizing comparable chemistry, however as a substitute of testing a blood drop, they constantly measure glucose within the interstitial fluid slightly below the pores and skin.

One of the principle causes these gadgets work so nicely is that the chemistry is extremely particular and managed. The enzymes concerned within the response nearly completely react with glucose, which it comes into direct contact with both within the blood or within the interstitial fluid. And, importantly, the glucose ranges in each interstitial fluid and in blood fluctuate equally.

But issues get wonky whenever you use tears. Glucose focus in tears is already decrease, and it fluctuates in ways in which aren’t at all times an correct illustration of blood glucose ranges. Things get even wonkier whenever you aren’t in touch with any fluid in any respect.

The idea of noninvasive monitoring is nothing new. When a sensible system, like an Apple Watch or a Fitbit, measures coronary heart fee, it does so by monitoring modifications within the blood quantity within the tiny blood vessels close to the pores and skin. The system shines a lightweight into your pores and skin and blood absorbs that gentle greater than the encircling tissue. As your coronary heart beats, blood quantity will increase and reduces. This shift is recorded in how a lot gentle is mirrored again to the sensor. By detecting this repeating sample over time, the system calculates what number of heartbeats happen per minute. With this know-how, wearables at the moment are extremely correct in relation to coronary heart fee.

So why is glucose so totally different? Heart fee focuses on shifts in whole blood quantity, which doesn’t actually work for glucose. Blood is made up of a combination of assorted cells, proteins, water, and different substances, and glucose is only a tiny fraction of that, says Judith Su, an affiliate professor of optical sciences and biomedical engineering on the University of Arizona. To detect glucose inside all these elements of blood, you principally should discover a approach to distinguish glucose from all these different issues.

“The main challenge is signal to noise,” Su tells Gizmodo. “In the laboratory you can easily distinguish glucose, but what makes it so difficult is the fact that the human body is quite complex.”

“Glucose produces this very small signal, and it’s present at very low concentrations compared to everything else in the body, particularly water, which dominates the signal in most measurement techniques. The second thing is it doesn’t necessarily have a very strong unique signature, so when you measure something, it tends to overlap with signals from other molecules, and then the third is it gets distorted by your tissue,” Su says.

Because of glucose’s finicky nature, researchers wanted a software that may be capable of establish one thing contained in the sugar molecule that was distinctive to it. That want for specificity drew scientists to Raman spectroscopy.

One photon in one million

Raman spectroscopy works by shining a laser onto a pattern and measuring how a tiny fraction of that gentle modifications after interacting with sure molecules, says Arianna Bresci, an optical engineer and postdoctoral affiliate at MIT’s Laser Biomedical Research Center.

With Raman spectroscopy, a tool sends a single-color laser beam into a cloth, comparable to pores and skin. Most of that gentle—99.999% of it—bounces again unchanged. But a really small fraction of these protons work together with the molecules and trigger them to vibrate. That interplay leads to these photons reflecting again in a barely however distinctly totally different manner than the opposite 99.999% of the photons. Because totally different molecules, comparable to glucose, have totally different bond buildings, they shift gentle in distinct patterns. From these distinct patterns, researchers can create what’s referred to as a Raman spectrum.

In excellent follow, a really delicate sensor measures the weak Raman-shifted gentle and filters out the unique laser gentle. Then, a pc system compares the measured spectrum of sunshine to recognized reference spectra. Once it matches the patterns, it may possibly establish the molecule. Finally, the depth of the attribute peaks displays how a lot glucose is current. So, a small peak would imply a decrease glucose studying and a bigger peak would imply a better glucose studying. It sounds easy, but it surely’s confirmed extremely tough.

“Among all the noninvasive optical techniques, Raman is an elite one because you can track a specific molecule,” Bresci says. “But the drawback is that the Raman signal is very low in intensity…for every one million photons that get in, just one is a Raman photon.”

Proof of idea

At MIT, Jeon Woong Kang, a analysis scientist on the college who research biomedical optics, is main the noninvasive glucose monitoring venture, which Bresci is part of. Back in 2020, the staff proved that they might precisely measure glucose Raman alerts immediately from the pores and skin. Part of the rationale for this breakthrough was that they discovered they might filter out the undesirable “noise” from different elements in physique tissue by shining near-infrared gentle onto the pores and skin at a special angle from the angle they collected the Raman sign.

This was a huge breakthrough, but it surely required a tool the dimensions of a desktop printer. Since that point, his staff has been engaged on making the system smaller. In December of 2025, the MIT staff published a study exhibiting that that they had efficiently created a working system the dimensions of a shoebox, they usually examined it in opposition to conventional glucose screens.

Ideally, it might finally make its manner right into a wearable system as small as an Apple Watch and even an Oura sensible ring. But that’s nonetheless a great distance off. Because Raman alerts are extraordinarily weak, the system to seize them requires massive, extremely delicate optical elements like a strong laser, lenses and filters, and a spectrometer. For glucose sensing particularly, that problem is multiplied as a result of the glucose sign in pores and skin is tiny in comparison with different substances round it. The smaller the system, the much less gentle it collects, usually, making it tougher to identify glucose (the sign) from all the opposite noise.

Another a part of the issue goes again to at least one purpose why Google’s sensible contacts failed. To create a tool that measures blood glucose, that you must be extremely correct or don’t even hassle making an attempt.

Now that the MIT staff has a working prototype, their subsequent targets are to proceed to make the system even smaller and take a look at it in medical trials to make sure it’s nearly as good as the present gold customary: the finger prick. They’ve turned this a part of the event over to a startup firm, Apollon, which Kang is a member of.

“Our industry partner, Apollon, has a plan to release the product into the market in the year of 2029 or 2030,” says Kang. “So that’s their timeline, because we need to go through the FDA clearance before selling it in the market.”

The way forward for noninvasive glucose monitoring is determined by whether or not researchers can shrink a complete laboratory room’s price of optics right into a wearable system.